Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review
Publication Date Mar 2014
Product Type Report
Pages 47
Single User License help $ 125.00
Site User License help $ 250.00
Corporate User License help $ 375.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sun Pharmaceutical Industries Limited (Sun Pharma) is an integrated specialty pharmaceutical company. It manufactures and markets wide range of pharmaceutical formulations as branded generics and generic pharmaceuticals in various therapeutic areas including psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology. The company carries out product development, process chemistry, and manufacturing of complex active pharmaceutical ingredients (APIs), and dosage forms. The company broadly classified its products into two categories, namely, Formulations and Active Pharmaceutical Ingredients (APIs).

Sun Pharmaceutical Industries Limited Key Recent Developments

Mar 06, 2014: Sun Pharma Seeks To Enter Into Japanese Generics Market
Feb 19, 2014: Sun Pharmaceutical Obtains FDA Approval For Osteoporosis Drug
Feb 13, 2014: Rekha Sethi appointed as an additional independent director of Sun Pharma Board
Feb 13, 2014: Sun Pharma reports financials for third quarter & nine months ending December 31st, 20131
Nov 08, 2013: DCGI Asks Sun Pharmaceutical To Suspend Clinical Research Activities At Mumbai Lab In India

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Sun Pharmaceutical Industries Limited - Key Facts 5
Sun Pharmaceutical Industries Limited - Key Employees 6
Sun Pharmaceutical Industries Limited - Key Employee Biographies 7
Sun Pharmaceutical Industries Limited - Major Products and Services 8
Sun Pharmaceutical Industries Limited - Pharmaceutical Pipeline Products Data 11
Sun Pharmaceutical Industries Limited, Pipeline Products by Therapy Area 11
Sun Pharmaceutical Industries Limited, Pipeline Products by Development Phase 12
Sun Pharmaceutical Industries Limited - History 15
Sun Pharmaceutical Industries Limited - Company Statement 20
Sun Pharmaceutical Industries Limited - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Sun Pharmaceutical Industries Limited - Key Manufacturing Facilities 23
Section 2 – Company Analysis 24
Sun Pharmaceutical Industries Limited - Business Description 24
Sun Pharmaceutical Industries Limited - Corporate Strategy 25
Sun Pharmaceutical Industries Limited - SWOT Analysis 26
SWOT Analysis - Overview 26
Sun Pharmaceutical Industries Limited - Strengths 26
Strength - Broad Product Portfolio 26
Strength - Strong Operational Base 26
Strength - Leading Position in the Domestic Market 26
Sun Pharmaceutical Industries Limited - Weaknesses 26
Weakness - Litigation Claims 26
Weakness - Exposure to Equity Financing 27
Sun Pharmaceutical Industries Limited - Opportunities 27
Opportunity - New Product Approvals 27
Opportunity - Expansion through Acquisitions 27
Opportunity - Growing Importance of Generics 27
Opportunity - Generics Growth Potential in India 28
Sun Pharmaceutical Industries Limited - Threats 28
Threat - Product Liability Claims 28
Threat - Stringent Government Regulations 28
Threat - Competitive Landscape 29
Sun Pharmaceutical Industries Limited - Key Competitors 30
Section 3 – Company Financial Ratios 31
Financial Ratios - Capital Market Ratios 31
Financial Ratios - Annual Ratios 31
Performance Chart 33
Financial Performance 33
Financial Ratios - Interim Ratios 34
Financial Ratios - Ratio Charts 35
Section 4 – Company’s Lifesciences Financial Deals and Alliances 36
Sun Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 36
Sun Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 37
Sun Pharmaceutical Industries Limited, Recent Deals Summary 38
Section 5 – Company’s Recent Developments 39
Sun Pharmaceutical Industries Limited, Recent Developments 39
Mar 06, 2014: Sun Pharma Seeks To Enter Into Japanese Generics Market 39
Feb 19, 2014: Sun Pharmaceutical Obtains FDA Approval For Osteoporosis Drug 39
Feb 13, 2014: Rekha Sethi appointed as an additional independent director of Sun Pharma Board 39
Feb 13, 2014: Sun Pharma reports financials for third quarter & nine months ending December 31st, 20131 39
Nov 08, 2013: DCGI Asks Sun Pharmaceutical To Suspend Clinical Research Activities At Mumbai Lab In India 41
Oct 28, 2013: Sun Pharmaceutical Addresses FDA’s Concerns At Caraco Facility 41
Oct 28, 2013: Sun Pharma to announce second quarter results on November 13, 2013 41
Jul 23, 2013: Sun Pharma to announce first quarter results on August 09, 2013 41
Jun 10, 2013: Sun Pharma Receives FDA Tentative Approval For Niacin ER Tablets 42
May 28, 2013: Sun Pharma Reports Revenue Of INR22.4 Billion In Fiscal 2013 42
Section 6 – Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
List of Tables
Sun Pharmaceutical Industries Limited, Key Facts 5
Sun Pharmaceutical Industries Limited, Key Employees 6
Sun Pharmaceutical Industries Limited, Key Employee Biographies 7
Sun Pharmaceutical Industries Limited, Major Products and Services 8
Sun Pharmaceutical Industries Limited, Number of Pipeline Products by Therapy Area 11
Sun Pharmaceutical Industries Limited, Number of Pipeline Products by Development Stage 12
Sun Pharmaceutical Industries Limited, Pipeline Products By Therapy Area and Development Phase 13
Sun Pharmaceutical Industries Limited, History 15
Sun Pharmaceutical Industries Limited, Other Locations 21
Sun Pharmaceutical Industries Limited, Subsidiaries 22
Sun Pharmaceutical Industries Limited, Key Manufacturing Facilities 23
Sun Pharmaceutical Industries Limited, Key Competitors 30
Sun Pharmaceutical Industries Limited, Ratios based on current share price 31
Sun Pharmaceutical Industries Limited, Annual Ratios 31
Sun Pharmaceutical Industries Limited, Interim Ratios 34
Sun Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 36
Sun Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 37
Sun Pharmaceutical Industries Limited, Recent Deals Summary 38
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46

List of Figures
List of Figures
Sun Pharmaceutical Industries Limited, Pipeline Products by Therapy Area 11
Sun Pharmaceutical Industries Limited, Pipeline Products by Development Phase 12
Sun Pharmaceutical Industries Limited, Performance Chart (2009 - 2013) 33
Sun Pharmaceutical Industries Limited, Ratio Charts 35
Sun Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 36
Sun Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 37

Title Date Price
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
China Pharmaceutical Guidebook Series (4) Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines
By Access China Management Consulting Ltd
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of tradition ...Read More
May 2015 $750.00
Latest Guide to Chinese Pharmaceutical GMP Regulations
By Access China Management Consulting Ltd
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about US$147 billion) ...Read More
Jul 2015 $750.00
"Acne vulgaris "- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acne vulgaris  - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and ...Read More
Apr 2016 $4950.00
"Acute coronary syndrome(ACS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute coronary syndrome (ACS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of th ...Read More
Apr 2016 $4950.00
"Acute heart failure(AHF)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the di ...Read More
Apr 2016 $4950.00
"Acute ischemic stroke (AIS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the ...Read More
Apr 2016 $4950.00
"Acute lymphoblastic leukemia (ALL)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute lymphoblastic leukemia (ALL) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview ...Read More
Apr 2016 $4950.00
"Age-related macular degeneration (AMD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overv ...Read More
Apr 2016 $4950.00
"Alzheimer’s disease (AD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the d ...Read More
Apr 2016 $4950.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  GlobalData

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z